Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Agilent Technologies A

Healthcare Biotechnology
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass... see more

Recent & Breaking News (NYSE:A)

Agilent to Participate in Jefferies Global Healthcare Conference

Business Wire 1 day ago

Agilent Names Michael Buckner as Chief Legal Officer

Business Wire 8 days ago

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Business Wire April 28, 2026

Agilent Showcases Cancer Research Solutions at AACR 2026

Business Wire April 15, 2026

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Business Wire April 1, 2026

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Business Wire March 26, 2026

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Business Wire March 19, 2026

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Business Wire March 11, 2026

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Business Wire March 9, 2026

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Business Wire February 25, 2026

Agilent to Participate in TD Cowen's 46th Annual Health Care Conference

Business Wire February 23, 2026

Agilent Announces Cash Dividend of 25.5 Cents per Share

Business Wire February 11, 2026

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Business Wire February 11, 2026

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Business Wire February 11, 2026

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

Business Wire February 4, 2026

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25

Business Wire February 2, 2026

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Business Wire January 23, 2026

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Business Wire December 16, 2025

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Business Wire December 1, 2025

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

Business Wire November 24, 2025

Podcasts